Feasibility of Developing Radiotracers for MDM2: Synthesis and Preliminary Evaluation of an <sup>18</sup>F-Labeled Analogue of the MDM2 Inhibitor SP-141.

Chitneni, Satish K; Zhou, Zhengyuan; Watts, Brian E; Zalutsky, Michael R

Feasibility of Developing Radiotracers for MDM2: Synthesis and Preliminary Evaluation of an ¹⁸F-Labeled Analogue of the MDM2 Inhibitor SP-141.

Chitneni, Satish K; Zhou, Zhengyuan; Watts, Brian E; Zalutsky, Michael R.

Afiliação

Chitneni SK; Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA.
Zhou Z; Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA.
Watts BE; Duke Human Vaccine Institute, Duke University, Durham, NC 27708, USA.
Zalutsky MR; Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA.

Pharmaceuticals (Basel) ; 14(4)2021 Apr 13.

Article em En | MEDLINE | ID: mdl-33924734

Palavras-chave

HepG2; MCF-7; MDM2; MDM2 inhibitor; PET; SP-141; fluorine-18; imaging; radiotracer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article